The U.S. Food and Drug Administration (FDA) has provided an update on its completed and ongoing actions to strengthen the safety and resiliency of the nation’s supply of infant formula, including specific actions the agency has taken to meet the recommendations made in FDA’s evaluation of the infant formula crisis response.
The U.S. Food and Drug Administration’s (FDA’s) proposed reorganization package for a unified Human Foods Program (HFP) and new Office of Regulatory Affairs (ORA) model is now under review at the U.S. Department of Health and Human Services (HHS). The proposed changes have implications that will affect the entire agency.
The U.S. Food and Drug Administration (FDA) has issued a final rule to complete administrative actions that reflect the agency’s June 2015 final determination that the use of partially hydrogenated oils (PHOs) in foods is no longer Generally Recognized as Safe (GRAS).
This article examines FDA's investigation of the 2022 regional outbreak of Salmonella Typhimurium on cantaloupe from the Southwest Indiana growing region, which caused 87 reported illnesses and 32 hospitalizations between July and September of that year, and discusses several themes and conclusions related to the outbreak, such as how "business as usual" will continue to produce the same results.
With the proliferation of cannabis legislation in many U.S. states, there is a need to address food safety oversight through a federal regulatory framework
This article discusses the work being done by the Federal Regulatory Framework (FRF) Working Group, a collaboration between the Foundation of Cannabis Unified Standards (FOCUS) and the Association of Food and Drug Officials (AFDO), to advocate for and develop a comprehensive and relevant roadmap for the federal regulatory framework of cannabis-infused edibles and beverages to address critical challenges and enhance consumer confidence.
Namandjé N. Bumpus, Ph.D., current Chief Scientist at the U.S. Food and Drug Administration (FDA), will become the next FDA Principal Deputy Commissioner when Janet Woodcock, M.D. retires in early 2024. One of Dr. Bumpus' main priorities is to assist in the proposed reorganization of a unified Human Foods Program, including creating a new model for the Office of Regulatory Affairs (ORA).
The U.S. Food and Drug Administration (FDA) recently rolled out additional resources to help entities comply with Section 204 of the Food Safety Modernization Act (FSMA 204), also known as the Food Traceability Final Rule.
In this episode of Food Safety Matters, we are joined by Blake Harris, CSCP, the Technical Director of IFT's Global Food Traceability Center (GFTC), and Alison Grantham, Ph.D., the Founder of Grow Well Consulting and a GFTC Member, to discuss the work of GFTC and how industry is preparing to comply with the requirements of FDA’s Food Traceability Final Rule under FSMA 204, which comes into effect on January 1, 2026.
The U.S. Food and Drug Administration (FDA) has made available a Small Entity Compliance Guide to help explain the actions a small entity must take to comply with recent changes made to Milk and Cream Products and Yogurt Products; Final Rule To Revoke the Standards for Lowfat Yogurt and Nonfat Yogurt and To Amend the Standard for Yogurt.
The U.S. Food and Drug Administration (FDA) will host three virtual, instructor-led Self-Assessment and Verification Audit (SAVA) Workshops for the Voluntary National Retail Food Regulatory Program Standards (Retail Food Regulatory Program Standards
) in 2024.